Your browser doesn't support javascript.
loading
Corrigendum to "Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up" [Clin Microbiol Infect] 29 (7) (2023) 918-923.
Barda, Noam; Lustig, Yaniv; Indenbaum, Victoria; Zibly, Daniel; Joseph, Gili; Asraf, Keren; Weiss-Ottolenghi, Yael; Amit, Sharon; Kliker, Limor; Abu-Kadar, Bian; Ben-Ami, Eytan; Canetti, Michal; Koren, Ravit; Katz-Likvornik, Shiri; Halpern, Osnat; Mendelson, Ella; Doolman, Ram; Harats, Dror; Kreiss, Yitshak; Mandelboim, Michal; Regev-Yochay, Gili.
Affiliation
  • Barda N; ARC Innovation Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Software and Information Systems Engineering, Ben-Gurion University of the Negev, Be'er Sheva, Israel; Epidemiology, Biostatistics and Community Health Services, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
  • Lustig Y; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; Central Virology Laboratory, Public Health Services, Ministry of Health, Tel-Hashomer, Ramat Gan, Israel.
  • Indenbaum V; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; Central Virology Laboratory, Public Health Services, Ministry of Health, Tel-Hashomer, Ramat Gan, Israel.
  • Zibly D; The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Joseph G; The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Asraf K; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; The Dworman Automated-Mega Laboratory, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.
  • Weiss-Ottolenghi Y; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Amit S; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; Clinical Microbiology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Kliker L; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; Central Virology Laboratory, Public Health Services, Ministry of Health, Tel-Hashomer, Ramat Gan, Israel.
  • Abu-Kadar B; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; Central Virology Laboratory, Public Health Services, Ministry of Health, Tel-Hashomer, Ramat Gan, Israel.
  • Ben-Ami E; Phase 1 clinical trials Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Canetti M; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Koren R; Central Virology Laboratory, Public Health Services, Ministry of Health, Tel-Hashomer, Ramat Gan, Israel.
  • Katz-Likvornik S; Central Virology Laboratory, Public Health Services, Ministry of Health, Tel-Hashomer, Ramat Gan, Israel.
  • Halpern O; Central Virology Laboratory, Public Health Services, Ministry of Health, Tel-Hashomer, Ramat Gan, Israel.
  • Mendelson E; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; Central Virology Laboratory, Public Health Services, Ministry of Health, Tel-Hashomer, Ramat Gan, Israel.
  • Doolman R; The Dworman Automated-Mega Laboratory, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.
  • Harats D; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; General Management, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Kreiss Y; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; General Management, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Mandelboim M; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; Central Virology Laboratory, Public Health Services, Ministry of Health, Tel-Hashomer, Ramat Gan, Israel.
  • Regev-Yochay G; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel; The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel. Electronic address: gili.regev@sheba.health.gov.il.
Clin Microbiol Infect ; 30(3): 409-413, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38128780

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Microbiol Infect Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2024 Document type: Article Affiliation country: Israel Publication country: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Microbiol Infect Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2024 Document type: Article Affiliation country: Israel Publication country: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM